Stockreport

Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million

Elutia, Inc. - Class A  (ELUT) 
PDF - Strengthened balance sheet to fully fund development and launch of NXT-41 platform - - Biologics for breast reconstruction represents $1.5 billion U.S. total addressa [Read more]